Brokerages forecast that Henry Schein, Inc. (NASDAQ:HSIC) will announce $0.83 earnings per share (EPS) for the current fiscal quarter, Zacks reports. Eight analysts have issued estimates for Henry Schein’s earnings, with estimates ranging from $0.78 to $0.86. Henry Schein posted earnings per share of $1.04 in the same quarter last year, which would suggest a negative year over year growth rate of 20.2%. The company is scheduled to issue its next earnings report on Monday, August 5th.
According to Zacks, analysts expect that Henry Schein will report full year earnings of $3.45 per share for the current financial year, with EPS estimates ranging from $3.41 to $3.50. For the next fiscal year, analysts forecast that the business will post earnings of $3.77 per share, with EPS estimates ranging from $3.66 to $3.95. Zacks Investment Research’s EPS averages are an average based on a survey of sell-side research firms that cover Henry Schein.
Henry Schein (NASDAQ:HSIC) last released its quarterly earnings data on Tuesday, May 7th. The company reported $0.80 earnings per share (EPS) for the quarter, beating the Zacks’ consensus estimate of $0.76 by $0.04. Henry Schein had a return on equity of 18.35% and a net margin of 4.10%. The business had revenue of $2.36 billion during the quarter, compared to analyst estimates of $2.36 billion. During the same quarter in the previous year, the firm posted $0.95 EPS. The business’s revenue for the quarter was up 3.8% compared to the same quarter last year.
In other Henry Schein news, Director Paul Brons sold 1,758 shares of Henry Schein stock in a transaction on Wednesday, June 12th. The stock was sold at an average price of $70.96, for a total transaction of $124,747.68. Following the sale, the director now owns 17,582 shares of the company’s stock, valued at approximately $1,247,618.72. The sale was disclosed in a document filed with the Securities & Exchange Commission, which can be accessed through this hyperlink. Also, CFO Steven Paladino sold 20,712 shares of Henry Schein stock in a transaction on Wednesday, June 19th. The shares were sold at an average price of $72.17, for a total value of $1,494,785.04. Following the sale, the chief financial officer now directly owns 166,233 shares in the company, valued at approximately $11,997,035.61. The disclosure for this sale can be found here. Insiders have sold a total of 49,668 shares of company stock worth $3,572,423 in the last ninety days. 1.06% of the stock is owned by company insiders.
Institutional investors have recently made changes to their positions in the business. Stephens Investment Management Group LLC raised its stake in Henry Schein by 3.8% during the 1st quarter. Stephens Investment Management Group LLC now owns 59,900 shares of the company’s stock valued at $3,601,000 after acquiring an additional 2,175 shares in the last quarter. Mn Services Vermogensbeheer B.V. raised its stake in shares of Henry Schein by 1.1% in the 1st quarter. Mn Services Vermogensbeheer B.V. now owns 84,529 shares of the company’s stock worth $5,081,000 after buying an additional 900 shares in the last quarter. Headinvest LLC raised its stake in shares of Henry Schein by 100.0% in the 4th quarter. Headinvest LLC now owns 13,160 shares of the company’s stock worth $1,033,000 after buying an additional 6,580 shares in the last quarter. Bell Rock Capital LLC bought a new stake in shares of Henry Schein in the 1st quarter worth $581,000. Finally, Bessemer Group Inc. raised its stake in shares of Henry Schein by 1.8% in the 4th quarter. Bessemer Group Inc. now owns 23,991 shares of the company’s stock worth $1,885,000 after buying an additional 420 shares in the last quarter.
NASDAQ:HSIC opened at $69.90 on Friday. Henry Schein has a 12-month low of $56.58 and a 12-month high of $91.35. The firm has a market cap of $10.27 billion, a price-to-earnings ratio of 16.92, a P/E/G ratio of 2.41 and a beta of 0.82. The company has a quick ratio of 0.93, a current ratio of 1.65 and a debt-to-equity ratio of 0.34. The firm’s 50 day moving average is $68.55.
Henry Schein Company Profile
Henry Schein, Inc provides health care products and services to dental practitioners and laboratories, physician practices, government, institutional health care clinics, and other alternate care clinics worldwide. It operates through two segments, Health Care Distribution, and Technology and Value-Added Services.
Featured Article: What does RSI mean?
For more information about research offerings from Zacks Investment Research, visit Zacks.com
Receive News & Ratings for Henry Schein Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Henry Schein and related companies with MarketBeat.com's FREE daily email newsletter.